Lisa Rossi, MD
Gastroenterology · Hartford, CTNPI 1275653933
Payments from drug & device makers
Across 566 payments — averaging $70.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phathom Pharmaceuticals, Inc.$23K
- AbbVie$9K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Bristol Myers Squibb$562
- Ardelyx, Inc.$497
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$25,86065%
- Travel & lodging$1,8165%
- Food & beverage$11,83230%
- Education$3351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 52 | $23,098 |
| AbbVie(2 entities) | 155 | $8,616 |
| Johnson & Johnson(2 entities) | 83 | $1,942 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $1,041 |
| Bristol Myers Squibb | 34 | $562 |
| Ardelyx, Inc. | 27 | $497 |
| E.r. Squibb & Sons, L.L.C. | 6 | $421 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $397 |
| Regeneron Healthcare Solutions, Inc. | 13 | $371 |
| Lilly USA, LLC | 12 | $325 |
| Pfizer | 15 | $249 |
| Ferring Pharmaceuticals Inc. | 13 | $204 |
| Sanofi | 8 | $200 |
| Gilead | 4 | $189 |
| QOL Medical, LLC | 6 | $183 |
| Ironwood Pharmaceuticals, Inc | 8 | $170 |
| Boehringer Ingelheim | 9 | $169 |
| Madrigal Pharmaceuticals | 2 | $168 |
| Boston Scientific | 1 | $146 |
| Fresenius Kabi USA, LLC | 6 | $139 |
| Celltrion USA Inc. | 5 | $116 |
| Nestle Healthcare Nutrition Inc. | 6 | $115 |
| Intercept Pharmaceuticals, Inc. | 5 | $103 |
| Aimmune Therapeutics, Inc. | 3 | $99 |
| Exact Sciences | 2 | $51 |
| Bayer | 2 | $50 |
| ERBE USA Inc | 2 | $40 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Alfasigma USA, Inc. | 2 | $33 |
| Organon | 2 | $31 |
| Sandoz | 1 | $22 |
| Shionogi Inc | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,843 in reported general payments places this provider in the 85th percentile of 326 gastroenterology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 29 | $302,325 |
| LinzessLinaclotide | 69 | $94,820 |
| Mesalamine | 66 | $46,235 |
| PentasaMesalamine | 14 | $24,656 |
| TrulancePlecanatide | 15 | $17,681 |
| Dexlansoprazole DrDexlansoprazole | 40 | $14,847 |
| CreonLipase/Protease/Amylase | 16 | $13,436 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 73 | $12,782 |
| Lubiprostone | 48 | $12,627 |
| Mesalamine DrMesalamine | 16 | $10,462 |
| NexiumEsomeprazole Magnesium | 11 | $9,011 |
| Omeprazole | 371 | $6,165 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 89 | $5,046 |
| Balsalazide Disodium | 19 | $4,236 |
| Sucralfate | 58 | $4,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $8,616 | $108,25585 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $397 | $17,68115 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $204 | $12,78273 claims |
| SandozLansoprazole | $22 | $2,68477 claims |
| Braintree Laboratories, Inc.Sutab | $36 | $1,94112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 326 gastroenterology providers in Connecticut.
Other gastroenterology in Hartford
- Martin HoffmanHartford$317K
- Colin SwalesHartford$285K
- Michael EinsteinHartford$139K
- David ChaletskyHartford$49K
- Pramod MistryNew Haven$6M
- Salam ZakkoBristol$2.7M
- Paul FeuerstadtHamden$1.4M
- Angelo ParedesMiddletown$1.3M
- James FrestonFarmington$778K
- Jill GaidosNew Haven$750K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.